Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (111-120 of 343) with videos related to

Pageof 35
Sort By:
Leukemia Research|February 25, 2018
The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphomaBrady E Beltrán, Sally Paredes, Esther Cotrina, et al.
Expert Review of Anticancer Therapy|April 11, 2022
Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemiaShayna Sarosiek, David Sermer, Andrew R Branagan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 27, 2022
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström MacroglobulinemiaDavid Sermer, Shayna Sarosiek, Andrew R Branagan, et al.
Leukemia & Lymphoma|May 18, 2012
Prognosis in primary effusion lymphoma is associated with the number of body cavities involvedJorge J Castillo, Helen Shum, Majid Lahijani, et al.
Leukemia & Lymphoma|September 21, 2010
Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecifiedJorge J Castillo, Domingo Morales, Pilar Quinones, et al.
British Journal of Haematology|July 6, 2017
Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemiaAdam J Olszewski, Chang Chen, Roee Gutman, et al.
American Journal of Hematology|March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significanceJorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
American Journal of Hematology|February 20, 2020
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and managementBrady E Beltran, Denisse Castro, Sally Paredes, et al.
Expert Review of Hematology|February 3, 2015
CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic optionsJorge J Castillo, Julio C Chavez, Francisco J Hernandez-Ilizaliturri, et al.
British Journal of Haematology|October 20, 2025
BCL-2 inhibition in Waldenström macroglobulinaemia and marginal zone lymphomaShayna Sarosiek, Uriel Suarez, Maria Fernandez-Turizo, et al.
Pageof 35

Showing results (111-120 of 343) with videos related to

Sort By:
Pageof 35
Leukemia Research|February 25, 2018
The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphomaBrady E Beltrán, Sally Paredes, Esther Cotrina, et al.
Expert Review of Anticancer Therapy|April 11, 2022
Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemiaShayna Sarosiek, David Sermer, Andrew R Branagan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 27, 2022
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström MacroglobulinemiaDavid Sermer, Shayna Sarosiek, Andrew R Branagan, et al.
Leukemia & Lymphoma|May 18, 2012
Prognosis in primary effusion lymphoma is associated with the number of body cavities involvedJorge J Castillo, Helen Shum, Majid Lahijani, et al.
Leukemia & Lymphoma|September 21, 2010
Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecifiedJorge J Castillo, Domingo Morales, Pilar Quinones, et al.
British Journal of Haematology|July 6, 2017
Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemiaAdam J Olszewski, Chang Chen, Roee Gutman, et al.
American Journal of Hematology|March 12, 2021
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significanceJorge J Castillo, Natalie S Callander, Muhamed Baljevic, et al.
American Journal of Hematology|February 20, 2020
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and managementBrady E Beltran, Denisse Castro, Sally Paredes, et al.
Expert Review of Hematology|February 3, 2015
CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic optionsJorge J Castillo, Julio C Chavez, Francisco J Hernandez-Ilizaliturri, et al.
British Journal of Haematology|October 20, 2025
BCL-2 inhibition in Waldenström macroglobulinaemia and marginal zone lymphomaShayna Sarosiek, Uriel Suarez, Maria Fernandez-Turizo, et al.
Pageof 35